AcquisitionOther
Sesen Bio, Inc. acquired Vicineum
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sesen Bio, Inc. -> Vicineum · $75 Million
The merger provides significant funding for Carisma's R&D pipeline to advance our revolutionary proprietary cell therapy platform.
Open source record (SEC) ↗